HUN · Huntsman Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $6.04B | $6.11B | $8.02B | $8.45B | $6.02B | $6.80B |
| Cost of Revenue | $5.17B | $5.21B | $6.48B | $6.68B | $4.92B | $5.42B |
| Gross Profit | $866.00M | $906.00M | $1.55B | $1.77B | $1.10B | $1.38B |
| R&D | $121.00M | $115.00M | $125.00M | $150.00M | $135.00M | $137.00M |
| SG&A | $671.00M | $689.00M | $711.00M | $851.00M | $775.00M | $786.00M |
| Total Operating Expenses | $891.00M | $822.00M | $874.00M | $980.00M | $667.00M | $913.00M |
| D&A | $289.00M | $278.00M | $281.00M | $296.00M | $283.00M | $270.00M |
| Operating Income | ($25.00M) | $84.00M | $672.00M | $795.00M | $433.00M | $469.00M |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | $61.00M | $64.00M | $186.00M | $209.00M | $46.00M | ($38.00M) |
| Net Income | ($189.00M) | $101.00M | $460.00M | $1.04B | $1.03B | $562.00M |
| EPS - Basic | ($1.10) | $0.57 | $2.29 | $4.77 | $4.69 | $2.46 |
| EPS - Diluted | ($1.10) | $0.57 | $2.27 | $4.72 | $4.66 | $2.44 |
Balance Sheet
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $429.00M | $540.00M | $654.00M | $1.04B | $1.59B | $525.00M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | $818.00M | $867.00M | $995.00M | $1.20B | $848.00M | $914.00M |
| Accounts Payable | - | - | $907.00M | $1.15B | $842.00M | $765.00M |
| Current Assets | $2.06B | $2.31B | $3.15B | $3.93B | $3.57B | $3.75B |
| Total Assets | $7.01B | $7.25B | $8.22B | $9.39B | $8.71B | $8.32B |
| Current Liabilities | $1.59B | $1.17B | $1.70B | $2.05B | $1.98B | $2.01B |
| Long-term Debt | $1.66B | $1.68B | $1.67B | $1.54B | $1.53B | $2.18B |
| Total Liabilities | $4.06B | $3.77B | $4.38B | $4.83B | $5.04B | $5.50B |
| Stockholders' Equity | $2.75B | $3.25B | $3.62B | $4.38B | $3.52B | $2.69B |
| Retained Earnings | $1.81B | $2.62B | $2.71B | $2.44B | $1.56B | $690.00M |
Cash Flow
| Line item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $263.00M | $209.00M | $914.00M | $952.00M | $253.00M | $897.00M |
| Investing Cash Flow | ($126.00M) | $305.00M | ($279.00M) | ($524.00M) | $1.46B | ($260.00M) |
| Financing Cash Flow | ($326.00M) | ($620.00M) | ($994.00M) | ($977.00M) | ($655.00M) | ($450.00M) |
| CapEx | $184.00M | $230.00M | $272.00M | $342.00M | $249.00M | $274.00M |
| Free Cash Flow | $79.00M | ($21.00M) | $642.00M | $610.00M | $4.00M | $623.00M |
Ratios
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 14.3% | 14.8% | 19.3% | 21.0% | 18.3% | 20.3% |
| Operating margin | -0.4% | 1.4% | 8.4% | 9.4% | 7.2% | 6.9% |
| EBITDA margin | 4.4% | 5.9% | 11.9% | 12.9% | 11.9% | 10.9% |
| Net margin | -3.1% | 1.7% | 5.7% | 12.4% | 17.2% | 8.3% |
| Free cash flow margin | 1.3% | -0.3% | 8.0% | 7.2% | 0.1% | 9.2% |
| FCF / Net income | -0.42 | -0.21 | 1.40 | 0.58 | 0.00 | 1.11 |
| R&D / Revenue | 2.0% | 1.9% | 1.6% | 1.8% | 2.2% | 2.0% |
| SG&A / Revenue | 11.1% | 11.3% | 8.9% | 10.1% | 12.9% | 11.6% |
| Effective tax rate | - | 38.8% | 28.8% | 16.7% | 4.3% | -7.3% |
| Return on assets | -2.7% | 1.4% | 5.6% | 11.1% | 11.9% | 6.8% |
| Return on equity | -6.9% | 3.1% | 12.7% | 23.9% | 29.4% | 20.9% |
| Return on invested capital | -0.4% | 1.0% | 9.0% | 11.2% | 8.2% | 9.6% |
| Liquidity | ||||||
| Current ratio | 1.30 | 1.97 | 1.85 | 1.92 | 1.80 | 1.87 |
| Quick ratio | 0.78 | 1.23 | 1.26 | 1.33 | 1.37 | 1.41 |
| Cash ratio | 0.27 | 0.46 | 0.38 | 0.51 | 0.80 | 0.26 |
| Leverage | ||||||
| Debt / Equity | 0.60 | 0.52 | 0.46 | 0.35 | 0.43 | 0.81 |
| Debt / Assets | 0.24 | 0.23 | 0.20 | 0.16 | 0.18 | 0.26 |
| Debt / EBITDA | 6.28 | 4.63 | 1.75 | 1.41 | 2.13 | 2.95 |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 2.55 | 2.23 | 2.27 | 2.15 | 2.48 | 3.10 |
| Liabilities / Assets | 0.58 | 0.52 | 0.53 | 0.51 | 0.58 | 0.66 |
| Efficiency | ||||||
| Asset turnover | 0.86 | 0.84 | 0.98 | 0.90 | 0.69 | 0.82 |
| Inventory turnover | 6.32 | 6.00 | 6.51 | 5.56 | 5.80 | 5.92 |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | 58d | 61d | 56d | 66d | 63d | 62d |
| Days payable outstanding | - | - | 51d | 63d | 62d | 52d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | 44.1x | 12.1x | 7.4x | 5.4x | - |
| P / B | 0.6x | 1.4x | 1.5x | 1.8x | 1.6x | - |
| P / S | 0.3x | 0.7x | 0.7x | 0.9x | 0.9x | - |
| EV / EBITDA | 11.2x | 15.5x | 6.9x | 7.5x | 7.7x | - |
| Growth | ||||||
| Revenue growth (YoY) | -1.2% | -23.8% | -5.1% | 40.5% | -11.5% | -27.5% |
| Revenue CAGR (3y) | -10.6% | 0.5% | 5.7% | -3.4% | -10.4% | -11.0% |
| Revenue CAGR (5y) | -2.3% | -8.2% | -0.8% | -2.6% | -10.2% | -10.1% |
| Gross profit growth (YoY) | -4.4% | -41.4% | -12.9% | 61.4% | -20.4% | -31.8% |
| Operating income growth (YoY) | - | -87.5% | -15.5% | 83.6% | -7.7% | -54.8% |
| Net income growth (YoY) | - | -78.0% | -56.0% | 1.1% | 84.0% | 66.8% |
| EPS growth (YoY) | - | -74.9% | -51.9% | 1.3% | 91.0% | 75.5% |
| EPS CAGR (3y) | - | -50.4% | -2.4% | 50.3% | 21.3% | 21.5% |
| EPS CAGR (5y) | - | -16.3% | -2.8% | 28.3% | 65.1% | 13.2% |
| FCF growth (YoY) | - | - | 5.2% | 15150.0% | -99.4% | -30.3% |
| FCF CAGR (5y) | -33.8% | - | -7.3% | -1.8% | - | 31.4% |
| Book value growth (YoY) | -15.4% | -10.3% | -17.2% | 24.4% | 31.0% | 6.6% |
Stability scores
Altman Z′
FY 2024 · bankruptcy risk
1.40
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2024 · 9-point quality
5/9
Neutral
- ✗Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Chemicals & Allied Products
Comparing Huntsman CORP against the 5 most active filers in the same SIC group.
Dividends
$0.68/share trailing 12 months · -32.4% YoY
| Ex-date | Per share |
|---|---|
| Mar 13, 2026 | $0.0880 |
| Dec 15, 2025 | $0.0880 |
| Sep 15, 2025 | $0.2500 |
| Jun 13, 2025 | $0.2500 |
| Mar 14, 2025 | $0.2500 |
| Dec 13, 2024 | $0.2500 |
| Sep 13, 2024 | $0.2500 |
| Jun 14, 2024 | $0.2500 |
| Mar 14, 2024 | $0.2500 |
| Dec 14, 2023 | $0.2380 |
| Sep 14, 2023 | $0.2380 |
| Jun 14, 2023 | $0.2380 |
| Mar 14, 2023 | $0.2380 |
| Dec 14, 2022 | $0.2130 |
| Sep 14, 2022 | $0.2130 |
| Jun 14, 2022 | $0.2130 |
| Mar 14, 2022 | $0.2130 |
| Dec 14, 2021 | $0.1880 |
| Sep 14, 2021 | $0.1880 |
| Jun 14, 2021 | $0.1880 |
| Mar 12, 2021 | $0.1630 |
| Dec 14, 2020 | $0.1630 |
| Sep 14, 2020 | $0.1630 |
| Jun 12, 2020 | $0.1630 |